Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 7 | |
Outperform | 13 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 20 analysts offering 12 month price targets for Ultragenyx Pharmaceutical Inc have a median target of 79.00, with a high estimate of 140.00 and a low estimate of 46.00. The median estimate represents a 34.40% increase from the last price of 58.78.
High | 138.2% | 140.00 |
Med | 34.4% | 79.00 |
Low | -21.7% | 46.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Oct 31, 2024.
Average growth rate | +6.07% |
Average growth rate | -23.48% |
More ▼
Revenue history & estimates in USD
Average growth rate | +10.24% |
Average growth rate | +53.47% |
More ▼